Search

… Monday, September 16, 2024 Selwyn M. Vickers, MD, FACS , the President and CEO of Memorial Sloan Cancer Center, is a renowned pancreatic cancer surgeon, health equity researcher, and hospital leader. But the title he is proudest of is ‘Dad.’  Dr. Vickers and his wife, Janice, have raised four grown children

A recently approved treatment approach dramatically improves the outlook for people with an aggressive form of lymphoma.

… Friday, February 8, 2019 Summary People newly diagnosed with peripheral T cell lymphoma have traditionally been treated with chemotherapy. A recent study showed that adding a drug called brentuximab vedotin to chemotherapy could stop the disease from progressing and improve survival. Peripheral T cell

Three faculty members from Memorial Sloan Kettering Cancer Center (MSK) and Sloan Kettering Institute (SKI) have been elected to the 2021 class of American Association for the Advancement of Science (AAAS) Fellows.

… Thursday, January 27, 2022 Three faculty members from Memorial Sloan Kettering Cancer Center (MSK) and Sloan Kettering Institute (SKI) have been elected to the 2021 class of American Association for the Advancement of Science (AAAS) Fellows. The new class of AAAS Fellows includes 564 scientists, engineers

Researchers from Memorial Sloan Kettering Cancer Center (MSK) are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia (ALL) by using one of the most promising methods of cancer treatment today, chimeric antigen receptor (CAR) T cells.

… Thursday, April 9, 2015 Researchers from Memorial Sloan Kettering Cancer Center (MSK) are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia (ALL) by using one of the most promising methods of cancer treatment today

A new type of engineered immune cell could be a potent treatment for cancers that have escaped other immunotherapies.

… Wednesday, January 19, 2022 Cancer treatment using chimeric antigen receptor (CAR) T cells has gained acclaim, thanks to striking success  in treating people with several types of advanced blood cancers such as leukemia . The approach, which was pioneered at Memorial Sloan Kettering Cancer Center, involves

The investigational oral drug MDV3100 significantly improved overall survival in patients with advanced prostate cancer, results of a large, phase III study show.

… Tuesday, January 31, 2012 The investigational oral drug MDV3100 significantly improved overall survival in patients with advanced prostate cancer , results of a large, phase III study show. The findings were presented today at the 2012 American Society of Clinical Oncology (ASCO) Genitourinary Cancers

Last week, Governor Kathy Hochul signed the New York State Budget for FY 2023 that includes a key provision which will allow more New Yorkers from underserved communities access to care at Memorial Sloan Kettering Cancer Center (MSK) and other NCI-designated cancer centers in the state.

… Monday, April 18, 2022 Last week, Governor Kathy Hochul signed the New York State Budget for FY 2023 that includes a key provision which will allow more New Yorkers from underserved communities access to care at Memorial Sloan Kettering Cancer Center (MSK) and other NCI-designated cancer centers in the

La semana pasada, la gobernadora Kathy Hochul firmó el presupuesto del estado de Nueva York para el año fiscal 2023, que incluye una disposición clave que permitirá que más neoyorquinos de comunidades marginadas accedan a la atención en Memorial Sloan Kettering Cancer Center (MSK) y otros centros oncológicos designados por el Instituto Nacional del Cáncer (NCI) en el estado.

… Monday, April 18, 2022 La semana pasada, la gobernadora Kathy Hochul firmó el presupuesto del estado de Nueva York para el año fiscal 2023, que incluye una disposición clave que permitirá que más neoyorquinos de comunidades marginadas accedan a la atención en Memorial Sloan Kettering Cancer Center (MSK

MSK nurses reaffirm their commitment to healing in the "Blessing of Hands" ceremony.

… Thursday, May 10, 2018 Close-up of nurse's hands being held and blessed by chaplain's hands. During the ceremony, members of the nursing staff stand before an MSK chaplain to have their hands cleansed with water and then blessed as vessels for providing care. Male chaplain holding hands of woman in white

The Fellows of the American Association for Cancer Research (AACR) have elected Charles L. Sawyers, MD, chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK), as their President-Elect for 2020–2021.

… Friday, June 12, 2020 The Fellows of the American Association for Cancer Research (AACR) have elected Charles L. Sawyers, MD , chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK), as their President-Elect for 2020–2021. He will assume the presidency